SYNDAX PHARMACEUTICALS INC (SNDX)
US87164F1057 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.5M | 1.5M | 139.7M 9,213.33% | 339.997K -100.00% | 125.56M | 98.944M -21.20% | 226.83M 129.25% | 408.25M 79.98% | 569.18M 39.42% | 710.98M 24.91% | 883.3M 24.24% | 1.05B 18.87% | ||
| EBITDA YoY % growth | -57.41M 24.28% | -71.31M -24.21% | 26.24M 136.80% | -152.514M -678.39% | -237.536M -51.51% | -147.789M 35.73% | -297.367M -101.21% | -175.849M 40.86% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -57.5M 24.24% | -71.4M -24.17% | 26.2M 136.69% | -152.792M -679.39% | -230.441M -51.48% | -263.714M -14.68% | -349.114M -32.38% | -249.621M 28.50% | -141.498M 43.31% | -14.79M 89.55% | 119.87M 910.48% | 239.15M 99.51% | 242.56M 1.43% | |
| Operating Margin | -3,833.33% | -4,760.00% | 18.75% | -44,939.40% | N/A | -210.03% | -352.84% | -110.05% | -34.66% | -2.60% | 16.86% | 27.07% | 23.10% | |
| EPS YoY % growth | -1.85 36.43% | -1.88 -1.62% | 0.43 122.87% | -2.58 -669.77% | -3.02 -20.82% | -2.89 2.28% | -3.78 -30.85% | -2.85 24.58% | -1.58 44.79% | -0.18 88.74% | 1.23 791.95% | 2.39 94.35% | 2.37 -0.85% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 99.40% | -1.08 -26.48% | -1.06 -32.86% | -1.02 -4.29% | -0.85 -14,173.50% |
| Revenue Q2Q % growth | 116.96M | 16.097M | 20.566M 487.60% | 27.499M 119.99% | 50.35M -56.95% |
| EBITDA Q2Q % growth | 58.927M 175.65% | -71.359M 10.25% | -68.36M 7.88% | -63.393M 29.22% | -25.643M -143.52% |
| EBIT Q2Q % growth | 18.047M 123.17% | -95.575M -20.20% | -93.04M -25.36% | -89.259M 0.36% | -72.542M -501.96% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.98 -34.25% | -1.14 | 0.16 | 13.67% |
| Q2 2024 Q2Q % growth | -0.80 -25.00% | -0.93 | 0.13 | 14.20% |
| Q1 2024 Q2Q % growth | -0.85 -44.07% | -1.00 | 0.15 | 14.84% |
| Q4 2023 Q2Q % growth | -1.00 -61.29% | -1.01 | 0.01 | 1.39% |
| Q3 2023 Q2Q % growth | -0.73 -25.86% | -0.81 | 0.08 | 10.03% |
| Q2 2023 Q2Q % growth | -0.64 -3.23% | -0.75 | 0.11 | 14.31% |
| Q1 2023 Q2Q % growth | -0.59 6.35% | -0.61 | 0.02 | 2.90% |
| Q4 2022 Q2Q % growth | -0.62 -134.25% | -0.66 | 0.04 | 6.31% |
| Q3 2022 Q2Q % growth | -0.58 -45.00% | -0.65 | 0.07 | 10.45% |
| Q2 2022 Q2Q % growth | -0.62 -40.91% | -0.65 | 0.03 | 4.53% |
| Q1 2022 Q2Q % growth | -0.63 -16.67% | -0.65 | 0.02 | 2.73% |
| Q4 2021 Q2Q % growth | 1.81 511.36% | 0.28 | 1.53 | 537.56% |
| Q3 2021 Q2Q % growth | -0.40 13.04% | -0.24 | -0.16 | -69.27% |
| Q2 2021 Q2Q % growth | -0.44 -4.76% | -0.73 | 0.29 | 39.67% |
| Q1 2021 Q2Q % growth | -0.54 3.57% | -0.66 | 0.12 | 18.34% |
| Q4 2020 Q2Q % growth | -0.44 | -0.50 | 0.06 | 11.33% |
| Q3 2020 Q2Q % growth | -0.46 -12.20% | -0.45 | -0.01 | -3.12% |
| Q2 2020 Q2Q % growth | -0.42 10.64% | -0.45 | 0.03 | 7.64% |
| Q1 2020 Q2Q % growth | -0.56 -5.66% | -0.52 | -0.04 | -6.99% |
| Q4 2019 Q2Q % growth | -0.44 37.14% | -0.43 | -0.01 | -1.43% |
| Q3 2019 Q2Q % growth | -0.41 39.71% | -0.48 | 0.07 | 14.61% |
| Q2 2019 Q2Q % growth | -0.47 36.49% | -0.44 | -0.03 | -7.53% |
| Q1 2019 Q2Q % growth | -0.53 32.91% | -0.57 | 0.04 | 6.40% |
| Q4 2018 Q2Q % growth | -0.70 | -0.68 | -0.02 | -2.72% |
| Q3 2018 Q2Q % growth | -0.68 | -0.77 | 0.09 | 12.20% |
| Q2 2018 Q2Q % growth | -0.74 | -0.89 | 0.15 | 16.56% |
| Q1 2018 Q2Q % growth | -0.79 | -0.98 | 0.19 | 19.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 12.5M | 11.423M | 1.077M | 9.43% |
| Q1 2023 Q2Q % growth | 437.141K | -437.141K | -100.00% | |
| Q4 2022 Q2Q % growth | -100.00% | 382.5K | -382.5K | -100.00% |
| Q3 2022 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q2 2022 Q2Q % growth | -100.00% | 1.403M | -1.403M | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 2.173M | -2.173M | -100.00% |
| Q4 2021 Q2Q % growth | 126.6M 31,550.00% | 59.854M | 66.746M | 111.51% |
| Q3 2021 Q2Q % growth | 12.4M 3,000.00% | 29.937M | -17.537M | -58.58% |
| Q2 2021 Q2Q % growth | 400K | 183.6K | 216.4K | 117.86% |
| Q1 2021 Q2Q % growth | 400K | 229.5K | 170.5K | 74.29% |
| Q4 2020 Q2Q % growth | 400K | 204K | 196K | 96.08% |
| Q3 2020 Q2Q % growth | 400K | 306K | 94K | 30.72% |
| Q2 2020 Q2Q % growth | 400K | 408K | -8K | -1.96% |
| Q1 2020 Q2Q % growth | 400K | 860.033K | -460.033K | -53.49% |
| Q4 2019 Q2Q % growth | 400K | 379.032K | 20.968K | 5.53% |
| Q3 2019 Q2Q % growth | 400K | 379.032K | 20.968K | 5.53% |
| Q2 2019 Q2Q % growth | 400K | 383.857K | 16.143K | 4.21% |
| Q1 2019 Q2Q % growth | 400K | 371.79K | 28.21K | 7.59% |
| Q4 2018 Q2Q % growth | 400K | 397.29K | 2.71K | 0.68% |
| Q3 2018 Q2Q % growth | 400K | 380.287K | 19.713K | 5.18% |
| Q2 2018 Q2Q % growth | 400K | 315.863K | 84.137K | 26.64% |
| Q1 2018 Q2Q % growth | 400K | 485.724K | -85.724K | -17.65% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 99.32% | 23.23% | 24.34% |
| Revenue | -8% | 292.42% | 254.13% | 319.29% |